Microsclerotherapy Treatment Market
According to Intent Market Research, the Microsclerotherapy Treatment Market is expected to grow from USD 11.7 billion in 2024-e at a CAGR of 6.1% to touch USD 16.7 billion by 2030. The Microsclerotherapy Treatment Market is dominated by key players such as Medtronic, Boston Scientific Corporation, AbbVie Inc., Merz Pharmaceuticals, Johnson & Johnson, Clarion Medical Technologies, B Braun Melsungen AG, Quanta System S.p.A., Vascular Solutions Inc., Inova Diagnostics, Ipsen Pharma, Scleromed, Pro Med Solutions, Revance Therapeutics, Medytox Inc.